Indonesia has received 1.2 million doses of a Covid-19 vaccine made by China's Sinovac, officials said, as the world's fourth most populous nation struggles to get soaring case rates under control.

The doses arrived in Jakarta late Sunday on a flight from Beijing, with another 1.8 million expected to be sent again next month.

Chinese pharmaceutical firm Sinovac Biotech has secured half a billion dollars in extra funding to produce its Covid-19 vaccine, it said Monday, as the country races to roll out a jab for general use.

Bethlehem lit up its Christmas tree on Saturday evening but without the usual crowds, as novel coronavirus restrictions put a damper on the start of Christmas festivities in the holy city. 

After separating from her husband in 2007, Katie Marcoux and her two young daughters moved in with her parents for financial reasons. She expected to stay a year at most.

Thirteen years later, Marcoux -- now remarried -- still lives in the house, along with her parents and one of her daughters. 

Britain's Queen Elizabeth II will receive the Pfizer-BioNTech coronavirus vaccine within weeks, reports on Sunday said, as the biggest immunization program in UK history begins next week.

The United States notched a record number of coronavirus cases in 24 hours for the third day running, as it was reported that Britain's Queen Elizabeth II will get a vaccine within weeks.

The World Health Organization has warned that vaccines will be no magic bullet for the coronavirus crisis as nations gear up for a massive rollout to tackle surging infections.

For the second day in a row, the United States on Friday notched a record number of coronavirus cases in 24 hours, reaching 225,201 new infections, according to a tally by Johns Hopkins University.

More than 65 million cases of the novel coronavirus have been detected worldwide, according to a tally from official sources compiled by AFP at 0750 GMT on Friday.

Moderna plans to have 100 to 125 million doses of its Covid-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday.

Between 85 and 100 million of the doses will be distributed in the United States, with the rest of the world receiving the remaining 15 to 25 million, the Cambridge, Massachusetts-based company said in a statement.